Both laboratory investigations and body composition quantification measures (eg, computed
tomography, CT) portray muscle loss in symptomatic Coronavirus disease 2019 (COVID-19) …

Skeletal muscle‐related symptoms are common in both acute coronavirus disease (Covid)‐
19 and post‐acute sequelae of Covid‐19 (PASC). In this narrative review, we discuss …

Background: Intensive care patients commonly develop muscle wasting and functional
impairment. However, the role of severe COVID-19 in the magnitude of muscle wasting and …

In long coronavirus disease 2019 (long COVID‐19), involvement of the musculoskeletal
system is characterised by the persistence or appearance of symptoms such as fatigue …

Introduction It has become increasingly evident that COVID-19 contributes to multiorgan
pathophysiology. The systemic inflammatory response increases both pro-inflammatory …

The COVID-19 pandemic has recently been the cause of a global public health emergency.
Frequently, elderly patients experience a marked loss of muscle mass and strength during …

Understanding the impact of COVID-19 on muscle strength may help to elucidate the organ
systems that contribute to acute and chronic COVID-19 sequelae. We questioned whether …

SARS-CoV-2 infection is often associated with severe inflammation, oxidative stress,
hypoxia and impaired physical activity. These factors all together contribute to muscle …

The rehabilitation of patients with COVID-19 after prolonged treatment in the intensive care
unit is often complex and challenging. Patients may develop a myriad of long-term multi …

Background and purpose Among post‐COVID‐19 symptoms, fatigue is reported as one of
the most common, even after mild acute infection, and as the cause of fatigue, myopathy …